Merck & Co., Inc. vs Novartis AG
Merck & Co., Inc. is worth $377.724B, 1.3× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $377.724B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $153.10 | $157.54 |
| Change | +17.39% | +1.90% |
| Revenue | $65.011B | $56.674B |
| Net income | $18.254B | $13.984B |
| Country | United States | Switzerland |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Merck & Co., Inc. bigger than Novartis AG?
- Merck & Co., Inc. has a market cap of $377.724B against $299.439B for Novartis AG, making it 1.3 times as valuable.
- Which company earns more, MRK or NVS?
- Merck & Co., Inc. reported net income of $18.254B and Novartis AG reported $13.984B in their most recent annual periods.